AAAAAA

   
Results: 1-7 |
Results: 7
Determination of in vivo absorption, metabolism, and transport of drugs bythe human intestinal wall and liver with a novel perfusion technique
Authors: von Richter, O Greiner, B Fromm, MF Fraser, R Omari, T Barclay, ML Dent, J Somogyi, AA Eichelbaum, M
Citation: O. Von Richter et al., Determination of in vivo absorption, metabolism, and transport of drugs bythe human intestinal wall and liver with a novel perfusion technique, CLIN PHARM, 70(3), 2001, pp. 217-227
Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: Impairment of its promoter activity
Authors: Pitarque, M von Richter, O Oke, B Berkkan, H Oscarson, M Ingelman-Sundberg, M
Citation: M. Pitarque et al., Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: Impairment of its promoter activity, BIOC BIOP R, 284(2), 2001, pp. 455-460
Rapid and highly sensitive method for the determination of verapamil, [H-2(7)]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry
Authors: von Richter, O Eichelbaum, M Schonberger, F Hofmann, U
Citation: O. Von Richter et al., Rapid and highly sensitive method for the determination of verapamil, [H-2(7)]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry, J CHROMAT B, 738(1), 2000, pp. 137-147
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
Authors: Hoffmeyer, S Burk, O von Richter, O Arnold, HP Brockmoller, J Johne, A Cascorbi, I Gerloff, T Roots, I Eichelbaum, M Brinkmann, U
Citation: S. Hoffmeyer et al., Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo, P NAS US, 97(7), 2000, pp. 3473-3478
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein
Authors: Pauli-Magnus, C von Richter, O Burk, O Ziegler, A Mettang, T Eichelbaum, M Fromm, MF
Citation: C. Pauli-magnus et al., Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein, J PHARM EXP, 293(2), 2000, pp. 376-382
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
Authors: Westphal, K Weinbrenner, A Zschiesche, M Franke, G Knoke, M Oertel, R Fritz, P von Richter, O Warzok, R Hachenberg, T Kauffmann, HM Schrenk, D Terhaag, B Kroemer, HK Siegmund, W
Citation: K. Westphal et al., Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction, CLIN PHARM, 68(4), 2000, pp. 345-355
Unexpected effect of verapamil on oral bioavailability of the beta-blockertalinolol in humans
Authors: Schwarz, UI Gramatte, T Krappweis, J Berndt, A Oertel, R von Richter, O Kirch, W
Citation: Ui. Schwarz et al., Unexpected effect of verapamil on oral bioavailability of the beta-blockertalinolol in humans, CLIN PHARM, 65(3), 1999, pp. 283-290
Risultati: 1-7 |